An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.

Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.

A cellular computing error wreaks havoc on vision.

New NIBR President Jay Bradner shares on drug discovery, his leadership style and what’s next for his career in biomedical research.

Novartis taps MOOC technology to share chemistry education with the world

Why are some sickle cell disease patients protected from the disease? Learn about our biomedical research in the field.